Baseline Adiponectin Concentration and Clinical Outcomes among Patients with Diabetes and Recent Acute Coronary Syndrome in the EXAMINE Trial

ConclusionsIn this contemporary population of patients with diabetes and ACS, adiponectin concentration was independently associated with increased risk of CV death, all‐cause mortality, and HF hospitalization. The relationship between adiponectin and CV outcomes is complex and deserves further study.

Source: Diabetes, Obesity and Metabolism - January 31, 2017 Category: Endocrinology Authors: Brian A. Bergmark, Christopher P. Cannon, William B. White, Petr Jarolim, Yuyin Liu, Marc P. Bonaca, Faiez Zannad, David A. Morrow Tags: ORIGINAL ARTICLE Source Type: research